Last reviewed · How we verify

ASU — Competitive Intelligence Brief

ASU (ASU) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Plant-derived anti-inflammatory agent. Area: Rheumatology / Orthopedics.

marketed Plant-derived anti-inflammatory agent Rheumatology / Orthopedics Small molecule Live · refreshed every 30 min

Target snapshot

ASU (ASU) — Laboratoires Expanscience S.A.. ASU (avocado-soybean unsaponifiables) is a plant extract that reduces inflammatory mediators and inhibits cartilage degradation in osteoarthritis.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
ASU TARGET ASU Laboratoires Expanscience S.A. marketed Plant-derived anti-inflammatory agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Plant-derived anti-inflammatory agent class)

  1. Laboratoires Expanscience S.A. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). ASU — Competitive Intelligence Brief. https://druglandscape.com/ci/asu. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: